Literature DB >> 10952399

The pancreas and inflammatory bowel diseases.

K R Herrlinger1, E F Stange.   

Abstract

This article reviews the literature and gives an overview on prevalence and possible explanations for pancreatic involvement in inflammatory bowel diseases (IBD). IBD patients have a markedly elevated risk for developing acute pancreatitis as well as pancreatic insufficiency. Multiple potential causes for pancreatitis in IBD patients exist. In the majority of cases acute pancreatitis appears to be related to drug side effects or local structural complications rather than a true extraintestinal manifestation of IBD. Nevertheless, some cases of acute pancreatitis remain unexplained. Prevalence of chronic pancreatitis in IBD patients also seems to be relatively high. However, etiology of pancreatic duct changes and/or the occurrence of exocrine insufficiency remain unclear. In most cases chronic pancreatitis is clinically unapparent, although in some patients it may be accompanied by clinically relevant exocrine insufficiency.

Entities:  

Mesh:

Year:  2000        PMID: 10952399     DOI: 10.1385/IJGC:27:3:171

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  94 in total

Review 1.  [Imaging diagnosis of diseases of the pancreas].

Authors:  J Glaser
Journal:  Dtsch Med Wochenschr       Date:  1990-09-07       Impact factor: 0.628

2.  Chronic pancreatitis associated with ulcerative colitis.

Authors:  D Forbes; R B Scott; C Trevenen; N Hershfield; D G Gall
Journal:  Clin Invest Med       Date:  1987-07       Impact factor: 0.825

Review 3.  Drug-associated pancreatitis: facts and fiction.

Authors:  M Rünzi; P Layer
Journal:  Pancreas       Date:  1996-07       Impact factor: 3.327

4.  The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease.

Authors:  A Lapidus; M Bångstad; M Aström; O Muhrbeck
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

Review 5.  Azathioprine: state of the art in inflammatory bowel disease.

Authors:  W J Sandborn
Journal:  Scand J Gastroenterol Suppl       Date:  1998

6.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

7.  Acute pancreatitis in Crohn's disease.

Authors:  P Weber; F Seibold; H Jenss
Journal:  J Clin Gastroenterol       Date:  1993-12       Impact factor: 3.062

8.  Relationship between pancreatic exocrine function and ductal morphology in chronic pancreatitis.

Authors:  J M Braganza; L P Hunt; F Warwick
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

9.  Duodenal fistulas in Crohn's disease.

Authors:  S Klein; A J Greenstein; D B Sachar
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

10.  Drug induced acute pancreatitis: incidence and severity.

Authors:  P G Lankisch; M Dröge; F Gottesleben
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  11 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

4.  Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Authors:  Deepak K Kadayakkara; Pamela L Beatty; Michael S Turner; Jelena M Janjic; Eric T Ahrens; Olivera J Finn
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

5.  Pancreatic involvement in pediatric inflammatory bowel diseases.

Authors:  Sabrina Cardile; Antonino Randazzo; Simona Valenti; Claudio Romano
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

6.  Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.

Authors:  Giovanni Maconi; Roberto Dominici; Mirko Molteni; Sandro Ardizzone; Matteo Bosani; Elisa Ferrara; Silvano Gallus; Mauro Panteghini; Gabriele Bianchi Porro
Journal:  Dig Dis Sci       Date:  2007-05-26       Impact factor: 3.199

Review 7.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Authors:  Alexander Teml; Elke Schaeffeler; Klaus R Herrlinger; Ulrich Klotz; Matthias Schwab
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 5.577

8.  Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease.

Authors:  Geum-Chae-Won Yi; Ka-Hyun Yoon; Jin-Bok Hwang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2012-12-31

9.  Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up.

Authors:  Ahmet Basturk; Aygen Yilmaz; Meryem Keceli; Reha Artan
Journal:  Prz Gastroenterol       Date:  2017-09-30

10.  Mesalizine-Induced Acute Pancreatitis and Interstitial Pneumonitis in a Patient with Ulcerative Colitis.

Authors:  Min Jae Chung; Jae Hee Lee; Kyung Rye Moon
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.